Streetbeat News

Partnerships

VIRI

Virios Therapeutics has received FDA guidance to progress IMC-1 to Phase 3 study for Fibromyalgia. Several life science companies are reviewing Phase 2 data and proposed Phase 3 program for a potential partnership. Virios has also submitted briefing materials to the FDA for a proposed investigational new drug application for IMC-2 as a treatment for Long-COVID. The company has filed for intellectual property protection for IMC-2 as treatment for LC and Alzheimer’s disease, which if granted, provides coverage to at least 2043. The company expects to have capital to support operations into Q3 of 2024.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 2:58 pm

RSG

Over 160 members of Teamsters Local 728 have ratified their fourth contract with Republic Services in Atlanta, according to Teamsters.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 2:54 pm

DIS

DKNG

PENN

Penn Entertainment reported Q3 revenue of $1.62 billion, slightly down from last year's $1.625 billion but ahead of the Street consensus estimate of $1.61 billion. The company also announced the launch of the ESPN Bet sports betting platform, in partnership with The Walt Disney Company, which will be initially available in 17 states. Penn's shares are up 7% to $21.01.

Portfolio Pulse from Chris Katje

November 02, 2023 | 2:21 pm

UBER

Uber has reached an agreement with New York Attorney General Letitia James, providing drivers with benefits and protections such as a minimum earnings standard and paid sick leave. The agreement also resolves the classification issue in New York. As part of the agreement, Uber will provide drivers with a minimum earnings floor, paid sick leave, in-app support in multiple languages, appeal options, and paid training. This follows a recent agreement with the New York State Department of Labor, where Uber will pay into the state's unemployment insurance fund.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:30 pm

AFRM

AMZN

Affirm Holdings Inc (NASDAQ:AFRM) shares are trading higher after the company announced an expanded partnership with Amazon.com Inc (NASDAQ: AMZN). The partnership will make Affirm the first pay-over-time option available at checkout on Amazon Business. The new feature will be rolled out on Thursday and is expected to be available for all Amazon Business customers by Black Friday.

Portfolio Pulse from Adam Eckert

November 02, 2023 | 1:29 pm

LYV

MA

Mastercard has partnered with Live Nation to offer exclusive live music benefits and experiences for cardholders across 19 markets in Europe and Asia. The partnership will also support the Priceless Planet Coalition.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:28 pm

DSX

Diana Shipping Inc. (NYSE:DSX) has announced a direct continuation of a time charter contract with Western Bulk Carriers AS for its Ultramax dry bulk vessel, the m/v DSI Aquila. The gross charter rate is $12,500 per day, for a period until at least November 10, 2024, and up to January 10, 2025. The new charter period is expected to commence on November 12, 2023. The employment of DSI Aquila is anticipated to generate approximately $4.49 million of gross revenue for the minimum scheduled period of the time charter.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:27 pm

GILD

Gilead and Kite Oncology have presented data at ASH 2023 demonstrating the survival benefits of their CAR T-cell therapy and showcasing the latest advances in their blood cancer portfolio. The data includes longer follow-up analyses of survival data showing the curative intent of Yescarta across different lines of therapy and age groups, including 65+. The durability of response and survival with Tecartus in adult relapsed/refractory B-cell acute lymphoblastic leukemia and mantle cell lymphoma was also observed in the largest real-world evidence studies to date.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:25 pm

VOR

Vor Bio (NASDAQ:VOR), a clinical-stage cell and genome engineering company, announced that preclinical and clinical data supporting its novel platform for treating acute myeloid leukemia (AML) will be presented at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition. The data includes updates from the VBP101 clinical trial and the CD33CART Study. The company also released data from a single cell analysis studying molecular signatures from 28 AML patients and from a preclinical collaboration with Janssen. A trial-in-progress poster will be presented on the Company's VBP301 clinical trial.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:21 pm

EEFT

Euronet (NASDAQ:EEFT) has announced a multi-year partnership with Banco Pichincha, Ecuador's largest private bank, for prepaid and debit card issuing and processing services. The partnership will involve the use of Euronet's Ren payments platform and will enable Pichincha to modernize its payments platform, comply with regulatory mandates, and introduce innovative products. The agreement also includes integration with Visa and Mastercard and will pave the way for the bank's digital transformation.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 1:19 pm